Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose vs Standard-dose Alteplase in Acute Ischemic Stroke
NCT03847883Phase 4Completed
- Sponsor
- Ministry of Public Health
- Start
- Jan 2011
- Primary completion
- Dec 2018
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of tissue-plasminogen activator in ischemic stroke, sponsored by Ministry of Public Health. Started Jan 2011; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03847883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03847883.